New Quincy Center
available to Lease
in Quincy, MA
posted on November 29, 2012
Director of Economic Development
The new offices and medical offices at New Quincy Center will be an authentic urban environment for health care, life sciences, higher education, and office tenants just eight miles from Boston. Connectivity between two signature office towers will potentially provide expansive floor plates of up to 60,000 square feet.
Biotech Infrastructure Amenities
The office and medical office component of Quincy Center is a unique 1.1M s.f. built-to-suit opportunity for large corporate users. New Quincy Center is a transformative $1.6 billion, 3.5 million-square-foot, mixed-use urban revitalization in the heart of a great American city. The 50-acre neighborhood of 1.1 million square feet of 1.1 million square feet of green office and medical office space, 700,000 square feet of retail, two new hotels, 1,400 residences, and multiple new parking garages. Every property will be anchored by a great public space and the Quincy Center MBTA Station. Co-developers The Beal Companies and Street-Works Development, share a common vision and commitment to the next generation of livable and sustainable downtowns. They bring a wealth of experience to the project.
All permits spanning 20 city blocks, and infrastructure improvements are well underway. Groundbreaking begins in mid-2013.
|Property Use||Lab, Office|
|Parking||This property has parking available|
|Date of Construction||2013|
|Property Owner||Beal Street Works|
Images (Click on images to view larger size)
MassBio is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Founded in 1985, MassBio represents over 600 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, and works to advance policy and promote education, while providing member programs and events, industry information, and services.
- December 9, 2014 Q & A with Dr. David Meeker, President and Chief Executive Officer of Genzyme
- December 9, 2014 Preparing the State's Next Generation of Biotechnology Leaders
- December 9, 2014 Personal Tragedy Calls Parents to Action
- December 9, 2014 MassCONNECT Graduates Celebrate Success
- December 9, 2014 Patient Advocacy Summit 2014: Live & Breathe